Gulf Times - BioNTech
BioNTech says can make mutation-beating vaccine in six weeks

BioNTech says can make mutation-beating vaccine in six weeks

The co-founder of BioNTech said Tuesday it was "highly likely" that its vaccine against the coronavirus works against the mutated strain detected in Britain, but it could also adapt the vaccine if necessary in six weeks.

First batch of Pfizer/BioNTEch Covid-19 vaccines arrives in Canada

First batch of Pfizer/BioNTEch Covid-19 vaccines arrives in Canada

The first Covid-19 vaccines landed on Canadian soil on Sunday, Prime Minister Justin Trudeau said, and some Canadians are expected to roll up their sleeves for a shot as soon as Monday.

Vaccine campaigns gather pace as US nears Pfizer approval

Vaccine campaigns gather pace as US nears Pfizer approval

The US could soon be the next country to launch an immunization campaign against the novel coronavirus after experts voted to recommend emergency approval for Pfizer-BioNTech's vaccine

WHO reviewing Pfizer vaccine for possible emergency listing

WHO reviewing Pfizer vaccine for possible emergency listing

The World Health Organization said on Wednesday it had received data from Pfizer and BioNTech on the Covid-19 vaccine and was reviewing it for "possible listing for emergency use", a benchmark for countries to authorise national use.

Pfizer-BioNTech seek EU emergency approval for Covid-19 vaccine, target Dec rollout

Pfizer-BioNTech seek EU emergency approval for Covid-19 vaccine, target Dec rollout

Pfizer Inc and BioNTech's Covid-19 vaccine could be rolled out in Europe this month, the companies said on Tuesday after they applied for EU emergency approval for the shot.

End of Pfizer trial paves way for a Covid shot this year

End of Pfizer trial paves way for a Covid shot this year

Final results from Pfizer Inc's Covid-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency US authorization within days, it said on Wednesday.

How two companies sprinted ahead in extraordinary race for a Covid vaccine

How two companies sprinted ahead in extraordinary race for a Covid vaccine

Just as the novel coronavirus was gaining a foothold in the United States in mid-March, Pfizer Inc Chief Executive Albert Bourla called on his top vaccine scientists and laid out a clear mission:

First lot of Covid vaccine expected by year-end or early 2021: al-Khal

First lot of Covid vaccine expected by year-end or early 2021: al-Khal

Qatar would be able to get an initial quantity of the Covid-19 vaccine developed by Pfizer and BioNTech, if approved by regulators, by the end of this year or early in 2021, a senior health official has said.

BioNTech to price vaccine below market rates, differentiate between regions

BioNTech to price vaccine below market rates, differentiate between regions

BioNTech, first in the race to produce evidence of a working COVID-19 vaccine, is planning to price the two-shot regimen below "typical market rates" and would differentiate pricing between countries or regions.

Germany expects EU to sign supply deal for BioNTech-Pfizer vaccine soon

Germany expects EU to sign supply deal for BioNTech-Pfizer vaccine soon

German Health Minister Jens Spahn expects the European Commision to sign a purchase agreement with BioNTech and its partner Pfizer for its potential vaccine against Covid-19 "in the coming days."

Spain to get first Pfizer vaccines in early 2021, Health Minister says

Spain to get first Pfizer vaccines in early 2021, Health Minister says

Spain would get the first vaccines against Covid-19 developed by US pharmaceuticals Pfizer and its partner BioNTech in early 2021, Health Minister Salvador Illa said on Tuesday.

All Qatar residents to get Covid-19 vaccine free

All Qatar residents to get Covid-19 vaccine free

The Ministry of Public Health (MoPH) has decided to provide the Covid-19 vaccine free of charge to all Qatar residents, a top official said Monday.